The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health

Description

The primary objectives of this application are to 1) investigate the effect of increased daily consumption of the Keto5 XOGenius beverage on outcomes associated with elevated risk for various neurocognitive and pathophysiological conditions/diseases. And 2) to investigate the effect of daily consumption of the Keto5 XOGenius beverage on the following variables: waist circumference, body weight, and body mass index (BMI).

Conditions

Cardiovascular Diseases, Hypertension, Cognitive Decline, Diet, Healthy

Study Overview

Study Details

Study overview

The primary objectives of this application are to 1) investigate the effect of increased daily consumption of the Keto5 XOGenius beverage on outcomes associated with elevated risk for various neurocognitive and pathophysiological conditions/diseases. And 2) to investigate the effect of daily consumption of the Keto5 XOGenius beverage on the following variables: waist circumference, body weight, and body mass index (BMI).

The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health

The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health

Condition
Cardiovascular Diseases
Intervention / Treatment

-

Contacts and Locations

Arlington

UT Arlington - Science and Engineering Innovation and Research Building, Arlington, Texas, United States, 76019

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Men and women who are between the ages of 18-50
  • * Individuals who have donated more than 550 ml of blood within the past 8 weeks will not have blood drawn from them in this protocol. However, if they remain interested in the study, and otherwise meet the inclusion criteria, then we may still opt to proceed with data collection.
  • * Food allergies
  • * Type I diabetes/Type II diabetes, and/or a history of hypoglycemia.
  • * History of irritable bowel syndrome or inflammatory bowel disease.
  • * Currently taking any medications that are designed to treat a cardiovascular or metabolic condition
  • * Pregnant women
  • * Breast feeding women
  • * Allergy to spandex/lycra/latex
  • * Anemia
  • * Use of prescription stimulants

Ages Eligible for Study

18 Years to 50 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

The University of Texas at Arlington,

Robert M Brothers, PhD, PRINCIPAL_INVESTIGATOR, University of Texas at Arlington

Study Record Dates

2025-08-31